ConductScience.org, home

Trial · NCT00004562

Results by group20

Each measurement the trial posted, group by group, in the words and numbers it posted.

OutcomeGroupCategoryValueSpreadUnits
Number of Patients That Had a First Occurrence of the Primary End Point (Composite of Death From Any Cause, Nonfatal MI, or Class IV HF)Percutaneous Coronary Intervention Group230participants
Number of Patients That Had a First Occurrence of the Primary End Point (Composite of Death From Any Cause, Nonfatal MI, or Class IV HF)Medical Therapy Group219participants
Number of Participants With Secondary Outcomes (Safety Events)Percutaneous Coronary Intervention GroupDeath from all causes150participants
Number of Participants With Secondary Outcomes (Safety Events)Medical Therapy GroupDeath from all causes153participants
Number of Participants With Secondary Outcomes (Safety Events)Percutaneous Coronary Intervention GroupFatal and nonfatal reinfarction77participants
Number of Participants With Secondary Outcomes (Safety Events)Medical Therapy GroupFatal and nonfatal reinfarction65participants
Number of Participants With Secondary Outcomes (Safety Events)Percutaneous Coronary Intervention GroupNonfatal reinfarction75participants
Number of Participants With Secondary Outcomes (Safety Events)Medical Therapy GroupNonfatal reinfarction61participants
Number of Participants With Secondary Outcomes (Safety Events)Percutaneous Coronary Intervention GroupNYHA class IV heart failure (HF)51participants
Number of Participants With Secondary Outcomes (Safety Events)Medical Therapy GroupNYHA class IV heart failure (HF)53participants
Number of Participants With Secondary Outcomes (Safety Events)Percutaneous Coronary Intervention GroupCardiovascular death77participants
Number of Participants With Secondary Outcomes (Safety Events)Medical Therapy GroupCardiovascular death81participants
Number of Participants With Secondary Outcomes (Safety Events)Percutaneous Coronary Intervention GroupDeath or nonfatal reinfarction212participants
Number of Participants With Secondary Outcomes (Safety Events)Medical Therapy GroupDeath or nonfatal reinfarction199participants
Number of Participants With Secondary Outcomes (Safety Events)Percutaneous Coronary Intervention GroupNYHA class III or IV HF76participants
Number of Participants With Secondary Outcomes (Safety Events)Medical Therapy GroupNYHA class III or IV HF74participants
Number of Participants With Secondary Outcomes (Safety Events)Percutaneous Coronary Intervention GroupDeath, reinfarction, or NYHA class III or IV HF249participants
Number of Participants With Secondary Outcomes (Safety Events)Medical Therapy GroupDeath, reinfarction, or NYHA class III or IV HF235participants
Number of Participants With Secondary Outcomes (Safety Events)Percutaneous Coronary Intervention GroupStroke29participants
Number of Participants With Secondary Outcomes (Safety Events)Medical Therapy GroupStroke24participants

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT00004562/results